Single-atom nanozymes: Bridging atomic design and biomedical function through structure–activity–property relationships
Advanced Drug Delivery Reviews · 2026-07 · 234 · 115879
DOI: 10.1016/j.addr.2026.115879 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Drug Delivery Reviews, 2026-07. Verfasst von Sin Yuan Chong und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemical Engineering, Australian Centre for NanoMedicine, The University of New South Wales, Sydney, NSW 2052, Australia. Hauptthemen laut MEDLINE: Nanostructures. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 143 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council, Australian Research Council.
Abstract (Originalsprache)
Single-atom nanozymes (SAzymes), featuring atomically dispersed active sites with well-defined coordination environments, have emerged as a powerful nanoplatform for mimicking metalloenzyme activity with high catalytic precision. However, their broader biomedical application remains limited by insufficient understanding of structure-function relationships and challenges in clinical translation. Here, we establish a structure-activity-property relationship (SAPR) framework to bridge atomic-level design with catalytic behavior and biomedical function. We first outline the fundamental principles for constructing single-atom active sites, followed by SAzyme-specific design strategies, including coordination environment modulation, electronic structure modulation, defect engineering, and multi-atom site construction. We then highlight how these atomic-level features govern key catalytic processes, i.e., reactive oxygen species (ROS) generation, reaction kinetics, as well as selectivity. Building on this framework, we discuss structure-driven biomedical applications of SAzymes in biosensing and catalytic therapy. Atomically defined active sites enable enhanced signal amplification, sensitivity, and reproducibility in biosensing, while in therapeutic applications, SAzymes regulate biological systems through ROS-mediated catalysis, microenvironment and metabolic modulation, and energy-assisted processes to address challenges such as tumor hypoxia, redox imbalance, and inflammation storms. Finally, key challenges, including stability in complex biological environments, protein corona effects, scalability, and biosafety, are critically discussed. This review provides a unified mechanistic perspective for the rational design and clinical translation of next-generation SAzyme-based nanomedicines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Chemical Engineering, Australian Centre for NanoMedicine, The University of New South Wales, Sydney, NSW 2052, Australia.
- School of Chemical Engineering, Australian Centre for NanoMedicine, The University of New South Wales, Sydney, NSW 2052, Australia; School of Biomedical Engineering, The University of New South Wales, Sydney, NSW 2052,…
- School of Chemical Engineering, Australian Centre for NanoMedicine, The University of New South Wales, Sydney, NSW 2052, Australia. Electronic address: jieying.liang@unsw.edu.au.
Förderung
- National Health and Medical Research Council
- Australian Research Council
Zitieren
APA
Chong, S. Y., Liang, K., & Liang, J. (2026). Single-atom nanozymes: Bridging atomic design and biomedical function through structure–activity–property relationships. Advanced Drug Delivery Reviews, 234, 115879. https://doi.org/10.1016/j.addr.2026.115879
Vancouver
Chong SY, Liang K, Liang J. Single-atom nanozymes: Bridging atomic design and biomedical function through structure–activity–property relationships. Advanced Drug Delivery Reviews. 2026;234:115879. doi:10.1016/j.addr.2026.115879
BibTeX
@article{Chong2026,
author = {Chong, Sin Yuan and Liang, Kang and Liang, Jieying},
title = {Single-atom nanozymes: Bridging atomic design and biomedical function through structure–activity–property relationships},
journal = {Advanced Drug Delivery Reviews},
year = {2026},
volume = {234},
pages = {115879},
doi = {10.1016/j.addr.2026.115879}
}
EUVIMED